in part , the rationale behind the recent regimen of methotrexate , bleomycin , doxorubicin ( adriamycin ) , cyclophosphamide , vincristine ( oncovin ) , and dexamethasone ( m-bacod ) is to protect the central nervous system , and the empiric proof of this protection awaits the follow-up results of trials currently underway .
C0010583
cyclophosphamide
C0083304
m-bacod